US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-01 08:32:46 Source：Culture Capsule news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
- Previous：Dortmund's injury concerns ease before facing PSG in Champions League semifinal
- Next：Jaguars cut WR Zay Jones, clearing a path to potentially sign five
Related articles
- The US is building a pier off Gaza to bring in humanitarian aid. Here's how it would work
- Our council is charging us £40 to have our BIN collected... there is no way we're paying up
- China dominates Thomas & Uber Cup group opener
- Bellingham and Mendy to miss Real Sociedad clash
- EPA rule bans toxic chemical methylene chloride, toxic solvent known to cause liver cancer
- Seahawks wrap up 8
- A Hindu festival in southwestern Pakistan brings a mountainous region to life
- Lionel Messi gets 2 goals in front of record New England crowd as Miami beats Revolution 4
- ACL injuries are more common in women soccer players than men. We may learn why
- Musa, Ibeagha score in second half to lead Dallas over Dynamo 2
- French cops drag pro
- Bryan Reynolds, Ke'Bryan Hayes hit back
- Conservative MP Dan Poulter defects to Labour in the latest blow to Rishi Sunak
- Jets go offense, offense and more offense around Aaron Rodgers throughout the NFL draft
- New Jersey seeks fourth round of offshore wind farm proposals as foes push back
- Rewind. Fast forward. African farmers are looking everywhere to navigate climate change
- Renowned Peruvian investigative reporter battles criminalized smear campaign — and cancer
- Chris Brady has 5 saves to help Fire play Atlanta to 0
- Jaguars cut WR Zay Jones, clearing a path to potentially sign five
- Chris Brady has 5 saves to help Fire play Atlanta to 0
Random recommendation
- Copyright © 2024 Powered by US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition ,Culture Capsule news portal sitemap